| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.00052 | 1 |